PVT1 and osteosarcoma: The lncRNA human plasmacytoma variant translocation 1 (PVT1) has been identified as an oncogene and regarded as an indicator for poor survival in pancreatic ductal adenocarcinoma [32], HCC [56], and osteosarcoma [84], although the target genes were not identical in these cancers.